SCHEMBL844980

SCHEMBL844980

Cc1ncccc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cccnc3C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPT P10636 2/20 0.44
POLB P06746 2/20 0.44
GAA P10253 1/20 0.44
PABPC1 P11940 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 2/20 0.42
HCRTR1 O43613 1/20 0.42
MEN1 O00255 1/20 0.42
RHOC P08134 1/20 0.42
RHOA P61586 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119551 0.91 DHODH (0.40) ALDH1A1CYP2C9CYP2C19MAPTPOLB
SCHEMBL845708 0.88 RHOC (0.46) ALDH1A1CYP2C9CYP2C19MAPTPABPC1
SCHEMBL845710 0.87 KMT2A (0.43) ALDH1A1CYP2C9CYP2C19MAPTGAA
SCHEMBL845008 0.86 ALDH1A1 (0.54) ALDH1A1CYP2C9CYP2C19MAPTPOLB
SCHEMBL845697 0.86 ALDH1A1 (0.45) ALDH1A1CYP2C9CYP2C19MAPTPABPC1
SCHEMBL845301 0.85 PABPC1 (0.51) ALDH1A1CYP2C9CYP2C19POLBGAA
SCHEMBL845686 0.84 HSD11B1 (0.43) ALDH1A1CYP2C9CYP2C19MAPTGAA
SCHEMBL845350 0.83 MAPK1 (0.49) ALDH1A1CYP2C9CYP2C19GAAPABPC1
SCHEMBL844996 0.83 CYP2C9 (0.50) ALDH1A1CYP2C9CYP2C19GAAPABPC1
SCHEMBL845059 0.83 ALDH1A1 (0.46) ALDH1A1CYP2C9CYP2C19PABPC1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed